Smith, M R <br/><br/>
Antisense oligodeoxyribonucleotide down-regulation of bcl-2 gene expression inhibits growth of the low-grade non-Hodgkin's lymphoma cell line WSU-FSCCL.  [electronic resource] 

 -  Cancer gene therapy  Sep 1995 
 - 207-12 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0929-1903 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Base Sequence<br/>Cell Division<br/>Dose-Response Relationship, Drug<br/>Down-Regulation--genetics<br/>Flow Cytometry<br/>Humans<br/>Immunohistochemistry<br/>Lymphoma, Non-Hodgkin--drug therapy<br/>Molecular Sequence Data<br/>Oligonucleotides, Antisense--chemistry<br/>Proto-Oncogene Proteins--genetics<br/>Proto-Oncogene Proteins c-bcl-2<br/>Tumor Cells, Cultured